Cardinal Health has agreed to purchase Integrated Oncology Network, a community cancer center operator, for $1.12 billion in cash. This acquisition will strengthen Cardinal's cancer-focused unit, Navista, giving it access to over 100 healthcare providers and 50 practice sites across 10 U.S. states. The move reflects the company's strategy to diversify beyond drug distribution into healthcare services, especially oncology, a growing market.

Rival companies like McKesson and Cencora (formerly AmerisourceBergen) have also made significant moves in the oncology space, as healthcare service providers expand their offerings beyond traditional drug distribution. Cardinal Health’s acquisition of Integrated Oncology Network enhances Navista’s ability to provide a range of support services to oncology practices, including reimbursement and management assistance. According to analysts, this is a positive step in expanding Cardinal Health's presence in the oncology sector.

The transaction is expected to contribute positively to Cardinal Health’s earnings within 12 months of closing. This acquisition comes as part of a broader trend in healthcare, where large companies are investing in specialized care services to stay competitive and meet growing patient demand in areas like cancer treatment.

Click here to read the original news story.